Option Care Health Reports 12.2% Revenue Growth in Q3 2025, Net Income Declines

Option Care Health, Inc. reported its financial results for the third quarter of 2025, revealing a net revenue of $1.435 billion, a 12.2% increase from $1.279 billion in the same period last year. For the nine months ending September 30, 2025, the company achieved a total revenue of $4.184 billion, up 14.6% from $3.652 billion in the prior year. Despite the revenue growth, net income for the third quarter decreased slightly to $51.8 million, compared to $53.9 million in the previous year, while net income for the nine months was $149.1 million, down from $151.7 million.

The company's gross profit for the third quarter was $272.9 million, representing a gross margin of 19.0%, down from 20.1% a year earlier. This decline in margin was attributed to higher costs associated with certain therapies, particularly in the chronic care segment, and a reduction in procurement spreads. Operating expenses also increased, with selling, general, and administrative expenses rising to $172.1 million from $157.0 million, driven by higher salaries and costs related to debt refinancing.

In terms of strategic developments, Option Care Health completed the acquisition of Intramed Plus, Inc. for $117.2 million in January 2025, which contributed to an increase in goodwill and intangible assets on the balance sheet. The company now operates a national network of 192 locations, including 87 full-service pharmacies and 105 stand-alone ambulatory infusion suites. The acquisition is expected to enhance the company's service offerings and operational efficiencies.

Operationally, the company reported a slight decrease in cash and cash equivalents, ending the quarter with $309.8 million, down from $412.6 million at the end of 2024. The decrease in cash flow from operations was primarily due to a reduction in accounts payable, while cash used in investing activities surged due to the acquisition of Intramed Plus. The company also repurchased $214.9 million of its common stock during the nine months, reflecting its commitment to returning value to shareholders.

Looking ahead, Option Care Health anticipates continued growth driven by organic expansion in its therapy portfolio and strategic acquisitions. The company remains focused on leveraging its existing infrastructure to control costs while enhancing service delivery. However, it acknowledges potential challenges related to market conditions and reimbursement environments that could impact future performance.